Reducing the Harm Associated with Injection Drug Use in Canada

Reference

1. Adlaf, E.M., Paglia, A. & Ivis, F.J. (1999). Drug use among Ontario students 1977-1999 (CAMH Research Document Series No. 5). Toronto, ON: Centre for Addiction and Mental Health.
   
   
2. Addictions Foundation of Manitoba (September 1997). Student survey. Final report. Winnipeg, MN: Addictions Foundation of Manitoba.
   
   
3. Poulin, C. & Baker, J. (November 1998). Nova Scotia student drug use 1998. Halifax, NS: Nova Scotia Department of Health, Drug Dependency.
   
   
4. Single, E., Gliksman, L. & LeCavalier, J. (no date). Towards a Canadian health research institute on addictions. Ottawa, ON: Canadian Centre on Substance Abuse.
   
   
5. Topp, J. (1994). HIV infection prevention measures for drug users. Second national workshop on HIV, alcohol and other drug use (proceedings). Ottawa, ON: Canadian Centre on Substance Abuse.
   
   
6. McAmmond and Associates (1997). Care, treatment and support for injection drug users living with HIV/AIDS. Ottawa, ON: Health Canada.
   
   
7. Single, E., Robson, L., Rehm, J. & Xie, X. (1999). Morbidity and mortality attributable to substance abuse in Canada. American Journal of Public Health, 89, 385-390.
   
   
8. Single, E., Rehm, J., Robson, L. & Truong, M. (2000). The relative risks and aetiologic fractions of different causes of disease and death attributable to alcohol, tobacco and illicit drug use in Canada. Canadian Medical Association Journal, 162, 1669-1675.
   
   
9. Nadeau, L. (1994). Risk taking contexts among addicts. Second national workshop on HIV, alcohol and other drug use (proceedings). Ottawa, ON: Canadian Centre on Substance Abuse.
   
   
10. Health Canada (2000). HIV and AIDS in Canada. Surveillance Report to December 31, 1999. Ottawa, ON: Health Canada.
    
    
11. Health Canada (2000). HIV/AIDS Epi Update-HIV/AIDS Among Injection Drug Users in Canada. Ottawa, ON: Health Canada.
    
    
12. Shabas, R. (1998) Report of the Meeting of the Expert Panel on Hepatitis C Epidemiology, June 17-18.
    
    
13. Zou, S. et al. (2000). Enhanced Surveillance of Acute Hepatitis B and Acute Hepatitis C in Four Health Regions in Canada, 1998-1999. Ottawa, ON: Health Canada.
    
    
14. Heintges, T. & Wands, J.R. (1997). Hepatitis C virus: Epidemiology and transmission, Hepatology, 25, 521-526.
    
    
15. Blume, S. (1997). Women and alcohol: Issues in social policy. In S. Wilsnack & R Wilsnack (Eds.), Gender and Alcohol: Individual and Social Perspectives. Rutgers, NJ: Rutgers Centre for Alcohol Studies.
    
    
16. Paltrow, L. (1998). Punishing Women for their behavior during pregnancy: An approach that undermines the health of women and children. In C.L. Wetherington & A.B. Roman (Eds.), Drug Addiction Research and the Health of Women. Washington, DC: National Institute on Drug Abuse.
    
    
17. Covenant House (1998). Information Brochure. Toronto, ON: Covenant House.
    
    
18. Radford, J. L., King, A. J. C., Warren, W. K. (1989). Street Youth and AIDS. Kingston, ON: Health and Welfare Canada.
    
    
19. Smart, R. G., Adlaf, E. M. (1991). Substance use and problems among Toronto street youth. British Journal of Addiction, 86, 999-1010.
    
    
20. Smart, R. G., Adlaf, E. M., Walsh, G. W., Zdanowicz, Y. (1992). Drifting & Doing: Changes in Drug Use Among Toronto Street Youth, 1990-1992. Toronto, ON: Addiction Research Foundation.
    
    
21. Adlaf, E., Zdanowicz, Y., Smart, R. (1996). Alcohol and other drug use among street-involved youth in Toronto. Addiction Research, 4, 11-24.
    
    
22. Adlaf, E., Zdanowicz, Y., Smart, R. (1996). Alcohol and other drug use among street-involved youth in Toronto. Addiction Research, 4, 11-24.
    
    
23. Scott, K. Indigenous Canadians, Chapter 5 in D. McKenzie, R. Williams and E. Single (Eds.) (1997). Canadian Profile: Alcohol, Tobacco and Other Drugs, 1997. Ottawa, ON: Canadian Centre on Substance Abuse.
    
    
24. Single, E. (March 2000). A socio-demographic portrait of drug users in Canada. Ottawa, ON: Health Canada.
    
    
25. Rothon, D., Strathdee, A., Cook, D., & Cornelisse, G.A. (1997). Determinants of HIV-Related High Risk Behaviours Among Young Offenders: A Window of Opportunity. Canadian Journal of Public Health.
    
    
26. Calzavara, L., Myers, T., Millson, M. Schlossberg, J., Burchell, A. (1997). Understand HIV-related Risk Behaviour in Prisons: The Inmates' Perspective. Toronto, ON: University of Toronto HIV, Social, Behavioural and Epidemiological Studies Unit.
    
    
27. Single, E., Robson, L., Xie, X. & Rehm, J. (1998). The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction, 93 (7), 983-998.
    
    
28. Hanvelt, R., Copley, T., Schneider, D. & Meagher, N. The Economic Costs and Resource Impacts of HIV/AIDS in BC (Community Health Resource Project, Sept., 1, 1999). NHRDP Project No. 6610-2372 AIDS.
    
    
29. Albert T. & Williams, G. (1998). The Economic Burden of HIV/AIDS in Canada. Canadian Policy Research Networks.
    
    
30. Meagher NL et al. (1999). Cost -effectiveness of the national investment for primary prevention of HIV: an assessment of Canada's investment using a stochastic simulation modeling approach (abstract C300). Presented at the Eighth Annual Canadian Conference of HIV/AIDS Research, May 1-4, 1999. Canadian Journal of Infectious Diseases 1999, 10 (Suppl B), 42B.
    
    
31. Albert, T. & Williams, G. (1998). The economic burden of HIV/AIDS in Canada. Ottawa, ON: Canadian Policy Research Network.
    
    
32. Kahn, J.G. (1996). The cost-effectiveness of HIV prevention targeting: How much more bang for the buck? American Journal of Public Health, 86 (12).
    
    
33. Larke, B. (May 2, 2000) Presentation to the Federal/Provincial/Territorial Heads of Corrections Working Group on HIV/AIDS. Moncton, NB.
    
    
34. Canadian Institute for Health Information (August 23, 2000). News Release: Organ Transplant Patients Living Longer.
    
    
35. Medical Research Council (June 1999). Identification of a research agenda for the diagnosis, care and prevention of hepatitis C in Canada.
    
    
36. Federal, Provincial and Territorial Advisory Committee on Population Health (September 1994). Strategies for population health. Investing in thehealth of Canadians. Ottawa, ON: Health Canada.
    
    
37. Single, E. (1999) A Harm Reduction Framework for Drug Policy in British Columbia, A discussion paper prepared for the British Columbia Federal/Provincial Harm Reduction Working Group.
    
    
38. Wiebe, J (1997). Addiction: Its position among health determinants. Alcohol and Tobacco Research Unit, University of Manitoba, Winnipeg.
    
    
39. Strathdee, S., Patrick, D., Currie, S., Cornelisse, P., Rekart, M., Montaner. J., Schechter, M., O'Shaughnessy, M. (1997). Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS, 11, 59-65.
    
    
40. Hurley, D.L. (1991) Women, alcohol and incest: An analytical review. Journal of Studies on Alcohol, 52(3), 253-268.
    
    
41. Frankl-Howard, D. (1992). Family violence: A review of theoretical and clinical literature. Ottawa, ON: Health and Welfare Canada.
    
    
42. Medrano, M. A., Desmond, D.P., Zule, W.A., Hatch, J.P., (1991). Histories of Childhood trauma and the effects on risky HIV behaviours in a sample of women drug users. American Journal of Alcohol and Drug Abuse, 25(4), 593-606.
    
    
43. Allers C, Benjack K, White J, & Roussey J. (1993). HIV vulnerability and the adult survivor of childhood sexual abuse. Child Abuse and Neglect, 17, 291-298.
    
    
44. Badgley, R. (1984). Sexual offences against children: Report of the committee on sexual offences against children and youth, Volumes 1 & 2. Ottawa, ON: Ministry of Supply and Services Canada.
    
    
45. Nurco, D., Blatchley, R., Hanlon, T., O'Grady, K. (1999). Early deviance and related risk factors in the children of narcotic addicts. American Journal of Drug and Alcohol Abuse, 25(1), 25-45.
    
    
46. Young, E. (2000), Saskatchewan Health, unpublished data.
    
    
47. Remis, R., et al. (1997). The HIV epidemic among injection drug users in Ontario: the situation in 1997. Report to the AIDS Bureau, Ontario Ministry of Health.
    
    
48. Millar, J. (1998). HIV, hepatitis, and injection drug use in British Columbia: pay now or pay later. Report from the Office of the Provincial Health Officer, BC Ministry of Health.
    
    
49. Remis, R., Leclerc. P., Vandal, A. (1998). La situation du sida et de l'infection au VIH au Québec 1996. Direction de santé publique de Montréal-Centre pour le Ministère de la Santé et des Services sociaux du Québec, p. A3-5.
    
    
50. Canadian Centre for Drug-Free Sport (CCDFS) (1993). National School Survey of Drugs and Sport-Final Report. Ottawa, ON: CCDFS.
    
    
51. Poulin, C. (1997) Canadian Community Epidemiology Network: Inaugural National Report. Ottawa, ON: Canadian Centre on Substance Abuse.
    
    
52. Poulin C., et al. (1992). An epidemic of hepatitis B among injection drug users in a rural area. Canadian Journal of Public Health, 83(2), 102-105.
    
    
53. Vooght M., et al. (1999). Developing a public health response to the emergence of HIV in Prince Albert, Saskatchewan (abstract C370P). Presented at the Eight Annual Canadian Conference of HIV/AIDS Research, May 1-4, 1999. Canadian Journal of Infectious Diseases, 10 (Suppl B), 61B.
    
    
54. Topp, J. (1994). HIV infection prevention measures for drug users. In Second National Workshop on HIV, Alcohol and Other Drug Use: Proceedings. Ottawa, ON: Canadian Centre on Substance Abuse, pp. 26-29.
    
    
55. McAmmond and Associates (1997). Care, Treatment and Support for Injection Drug Users Living with HIV/AIDS. Ottawa, ON: Health Canada.
    
    
56. Single, E. (2000). A Socio-demographic Portrait of Drug Users in Canada. Ottawa, ON: Health Canada.
    
    
57. Saskatchewan Alcohol and Drug Abuse Commission (SADAC) (1993). SADAC client profile 1991/92: injection drug users in treatment. Focus sheet. Regina, SK: SADAC.
    
    
58. Millson, P., Myers, T., Rankin, J., McLaughlin, B., Major, C., Mindell, W., Coates, R., Rigby, J., Strathdee, S. (1995). Prevalence of Human Immunodeficiency Virus and associated risk factors in injection drug users in Toronto. Can. Journal of Public Health, 86, 176-180.
    
    
59. Topp, J. HIV (1994) infection prevention measures for drug users. Pp. 26-29 in Second National Workshop on HIV, Alcohol and Other Drug Use: Proceedings. Ottawa, ON: Canadian Centre on Substance Abuse.
    
    
60. Belanger, D., Alary, M., Godin, G., Bernard, P., Noel, L., Poulin, C., Parent, R., Lachance, C., Classens, C. (1996) Identification of sub-groups at high risk of sharing used needles among injection drug users participating in a needle-exchange program. University of Laval: unpublished paper.
    
    
61. Millson, M., Coates, R., Devenyi, P., Franklin, T., Rankin, J. (1990). AIDS-related knowledge, attitudes and behaviour in injection drug users attending a Toronto treatment facility. Can. Journal of Public Health, 81, 46-52.
    
    
62. Hewitt, D., Vinje, G. (1991). Injection drug use among addictions treatment clients in Alberta: implications for the spread of AIDS. Canadian Journal of Public Health, 82, 205-207.
    
    
63. Strathdee, S., Patrick, D., Currie, S., Cornelisse, P., Reckart, M., Montaner, J., Schechter, M., O'Shaughnessy, M. (1997). Needle exchange is not enough: lessons from Vancouver injecting drug use study. AIDS, 11, F59-F65.
    
    
64. Stratton, E., Lior, L., Gully, P., Archibald, C., Lee, S., Chaudhary, R., Woodford, E., Scott, J. (1997). HIV, HBV and HCV and risk behaviours in a semi-rural community in Canada. Unpublished paper. Halifax, NS: Nova Scotia Department of Health.
    
    
65. Poulin C., Alary, M., Bernier, F., Ringuet, J. (1998). HIV-1 prevalence among drug users participating to a STD screening program on urine samples in a needle exchange program in Quebec City. Canadian Journal of Infectious Disease, 9, 36A.
    
    
66. Elnitsky, S., Abernathy, T.(1993). Calgary's needle exchange program: profile of injection drug users. Can. Journal of Public Health, 84, 177-180.
    
    
67. Wolfe, R., Sykes, B.(1992). Needleworks: Prevention of HIV in Injection Drug Users: Final Report and Evaluation. Edmonton, AB: Board of Health.
    
    
68. Millson, M., Coates, R., Devenyi, P., Franklin, T., Rankin, J. (1990). AIDS-related knowledge, attitudes and behaviour in injection drug users attending a Toronto treatment facility. Can. Journal of Public Health, 81, 46-52.
    
    
69. Poulin C., et al. (1992). An epidemic of hepatitis B among injection drug users in a rural area. Canadian Journal of Public Health, 83(2),102-105.
    
    
70. Bruneau, J., Lamothe, F., Franco, E., Lachance, N., Desy, M., Soto, J., Vincelette, J. (1997). High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am. Journal of Epidemiology, 146, 994-1002.
    
    
71. Millson, M., Coates, R., Devenyi, P., Franklin, T., Rankin, J. (1990). AIDS-related knowledge, attitudes and behaviour in injection drug users attending a Toronto treatment facility. Can. Journal of Public Health, 81, 46-52.
    
    
72. Millson, P., Myers, T., Rankin, J., McLaughlin, B., Major, C., Mindell, W., Coates, R., Rigby, J., Strathdee, S. (1995). Prevalence of Human Immunodeficiency Virus and associated risk factors in injection drug users in Toronto. Can. Journal of Public Health, 86, 176-180.
    
    
73. Archibald, C., Ofner, M., Patrick, D., Strathdee, S.(1996). A study of risk factors for HIV infection among Vancouver's injection drug using community: summary of final results. Vancouver: The Point Project. unpublished report.
    
    
74. Bruneau, J., Lamothe, F., Franco, E., Lachance, N., Desy, M., Soto, J., Vincelette, J.(1997). High rates of HIV infection among injection drug users
    participating in needle exchange programs in Montreal: results of a cohort study. Am. Journal of Epidemiology, 146, 994-1002.
    
    
75. Fischer, B., Medved, W., Gliksman, L., Rehm, J. (1999). Illicit opiate users in Toronto: a profile of current users. Addiction Research, 7, 377-415.
    
    
76. Fischer, B., Medved, W., Gliksman, L., Rehm, J. (1999). Illicit opiate users in Toronto: a profile of current users. Addiction Research, 7, 377-415.
    
    
77. Fischer, B., Medved, W., Gliksman, L., Rehm, J. (1999). Illicit opiate users in Toronto: a profile of current users. Addiction Research, 7, 377-415.
    
    
78. Single, E., Robson, L., Rehm, J., Xie, X.(1996b). Morbidity and mortality attributable to substance abuse in Canada. American Journal of Public Health, 89, 385-390.
    
    
79. Single, E, Rehm, J, Robson, L, Truong, M (2000). The relative risks and aetiologic fractions of different causes of disease and death attributable to alcohol, tobacco and illicit drug use in Canada, Canadian Medical Association Journal, 162, 1669-1675.
    
    
80. Single, E., Robson, L., Rehm, J., Xie, X (1996b). Morbidity and mortality attributable to substance abuse in Canada. American Journal of Public Health, 89, 385-390.
    
    
81. Single, E., Robson, L., Rehm, J., Xie, X (1999b). Morbidity and mortality attributable to substance abuse in Canada. American Journal of Public Health, 89, 385-390.
    
    
82. Single, E., Robson, L., Rehm, J., Xie, X (1999b). Morbidity and mortality attributable to substance abuse in Canada. American Journal of Public Health, 89, 385-390.
    
    
83. Fischer, B., Medved, W., Gliksman, L., Rehm, J. (1999). Illicit opiate users in Toronto: a profile of current users. Addiction Research, 7, 377-415.
    
    
84. Fischer, B., Medved, W., Gliksman, L., Rehm, J. (1999). Illicit opiate users in Toronto: a profile of current users. Addiction Research, 7, 377-415.
    
    
85. Nadeau, L. (1994a) Risk taking contexts among addicts. In: Second National Workshop on HIV, Alcohol and Other Drug Use; Proceedings. Ottawa, ON: Canadian Centre on Substance Abuse.
    
    
86. Health Canada (2000). HIV and AIDS in Canada: Surveillance Report to December 31, 1999, Ottawa, ON: Health Canada.
    
    
87. Zou, S. et al. (2000). Enhanced Surveillance of Acute Hepatitis B and Acute Hepatitis C in Four Health Regions in Canada, 1998-1999. Ottawa, ON: Health Canada.
    
    
88. Leshner, A.I. Drug Abuse and Mental Disorders: Comorbidity Is Reality. NIDA Notes, Director's Column, 14 (4).
    
    
89. Poulin, C. (1997). Illicit Drugs. In Health Canada (Ed.) Canada's Alcohol and other Drugs Survey 1994: A Discussion of the Findings, Ottawa, ON: Health Canada.
    
    
90. Single, E. (2000). A Socio-demographic Portrait of Drug Users in Canada. Internal report commissioned by the HIV/AIDS Prevention and Community Action Programs. Ottawa, ON: Health Canada.
    
    
91. Fischer, B., Medved, W., Gliksman, L., Rehm, J. (1999). Illicit opiate users in Toronto: a profile of current users. Addiction Research, 7, 377-415.
    
    
92. Health Canada. (1994). Family Violence and Substance Abuse (1993). Ottawa, ON: the National Clearinghouse on Family Violence, Cat H72-22/14-1994E.
    
    
93. Correctional Services of Canada. (1990). Final Report of the Working Group on Reducing Addictions. Ottawa, ON: Correctional Services of Canada, 1990.
    
    
94. Brochu, S., Guyon, L.(1995). The issue of addiction among a sample of incarcerated women. 37th International Congress on Alcohol and Drug Dependence.
    
    
95. Brochu, S. (1995). Estimating The costs of drug-related crime. 2nd International Symposium on the Social and Economic Costs of Substance Abuse, Montebello, Quebec.
    
    
96. Hall, W., Bell, J., Carless, J.(1993). Crime and drug use among applicants for methadone maintenance. Drug and Alcohol Dependence, 31, 123-129.
    
    
97. Millson, P., Myers, T., Rankin, J., McLaughlin, B., Major, C., Mindell, W., Coates, R., Rigby, J., Strathdee, S. (1995). Prevalence of Human Immunodeficiency Virus and associated risk factors in injection drug users in Toronto. Can. Journal of Public Health, 86, 176-180.
    
    
98. Brunelle, N., Brochu, S. (1995). La prédiction de la délinquance et de la toxicomanie: les risques, les facteurs de risque. 63ieme Congrés de l'ACFAS.
    
    
99. Fagan, J., Weis, J., Cheng, Y. (1990). Delinquency and substance use among inner city students. Journal of Drug Issues, 20, 351-402.
    
    
100. McBride, D., McCoy, C. (1981). Crime and drug using behavior. Criminology, 19, 281-302.
     
     
101. Single, E., Robson, L., Xie, X., Rehm, J. (1998). The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction, 93(7), 983-998.
     
     
102. Millar, J. (1998). HIV, hepatitis, and injection drug use in British Columbia: pay now or pay later. Report from the Office of the Provincial Health Officer, BC Ministry of Health.
     
     
103. Fischer, B., et al. (1999). Comparing opiate users in methadone treatment with untreated opiate users: results of a follow-up study with a Toronto opiate user cohort. Canadian Journal of Public Health, 90 (5).
     
     
104. Albert, T. & Williams, G. (1998). The Economic Burden of HIV/AIDS in Canada. Canadian Policy Research Networks.
     
     
105. Hanvelt, R., Copley, T., Schneider, D. & Meagher, N. (1999). The Economic Costs and Resource Impacts of HIV/AIDS in British Columbia. NHRDP Project No. 6610-2372-AIDS.
     
     
106. Meagher NL et al. (1999). Cost-effectiveness of the national investment for primary prevention of HIV: an assessment of Canada's investment using a stochastic simulation modeling approach (abstract C300). Presented at the Eight Annual Canadian Conference of HIV/AIDS Research, May 1-4, 1999. Canadian Journal of Infectious Diseases, 10(Suppl B), 42B.
     
     
107. Larke, B. (May 2, 2000) Presentation to the Federal/Provincial/Territorial Heads of Corrections Working Group on HIV/AIDS. Moncton, NB.
     
     
108. Canadian Institute for Health Information (August 23, 2000). News Release: Organ Transplant Patients Living Longer.
     
     
109. Medical Research Council (1999). Identification of a research agenda for the diagnosis, care and prevention of hepatitis C in Canada.
     
     
110. Myers, T., Bullock, S., Calzavara, L., Cockerill, R., Marshall, V. (1997). Differences in sexual risk-taking behavior with state of inebriation in an aboriginal population in Ontario, Canada. Journal of Studies on Alcohol, 58, 312-322.
     
     
111. Scott, K. Indigenous Canadians, Chapter 5 in D. McKenzie, R. Williams and E. Single (Eds.) (1997). Canadian Profile: Alcohol, Tobacco and Other Drugs, 1997, Ottawa, ON: Canadian Centre on Substance Abuse.
     
     
112. Scott, K. (1997). Indigenous Canadians, Chapter 5 in D. McKenzie, R. Williams and E. Single (Eds.). Canadian Profile: Alcohol, Tobacco and Other Drugs, 1997, Ottawa, ON: Canadian Centre on Substance Abuse.
     
     
113. Gfellner, B., Hundelby, H. (1995). Patterns of drug use among native and white adolescents 1990-1993. Canadian Journal of Public Health, 86, 95-97.
     
     
114. Scott, K. Indigenous Canadians, Chapter 5 in D. McKenzie, R. Williams and E. Single (Eds.). Canadian Profile: Alcohol, Tobacco and Other Drugs, Ottawa, ON: Canadian Centre on Substance Abuse.
     
     
115. Single, E. (2000). A Socio-demographic Portrait of Drug Users in Canada. Internal report commissioned by the HIV/AIDS Prevention and Community Action Programs. Ottawa, ON: Health Canada.
     
     
116. Strathdee, S., Patrick, D., Currie, S., Cornelisse, P., Reckart, M., Montaner, J., Schechter, M., O'Shaughnessy, M. (1997). Needle exchange is not enough: lessons from Vancouver injecting drug use study. AIDS, 11, F59-F65.
     
     
117. Saskatchewan Alcohol and Drug Abuse Commission (SADAC) (1993). SADAC client profile 1991/92: injection drug users in treatment. Focus sheet. Regina, SK: SADAC.
     
     
118. Health Canada. (2000). HIV/AIDS Epi Update—HIV and AIDS among Aboriginal peoples in Canada. Ottawa, ON: Health Canada.
     
     
119. British Columbia Aboriginal AIDS Task Force (1999). The Red Road-Pathways to Wholeness: An Aboriginal Strategy for HIV and AIDS in B.C. Victoria: B.C. Aboriginal AIDS Task Force.
     
     
120. Minuk, G. (1999). Viral Hepatitis in a Population of Urban, North American, Street-Involved People. Ottawa, ON: Health Canada.
     
     
121. Canadian HIV/AIDS Legal Network (1999). Injection Drug Use and HIV/AIDS: Legal and Ethical Issues.
     
     
122. Brochu, S. (1995). Estimating the costs of drug-related crime. 2nd International Symposium on the Social and Economic Costs of Substance Abuse, Montebello, Quebec.
     
     
123. Calzavara, L., Myers, T., Millson, M. Schlossberg, J., Burchell, A. (1997). Understand HIV-related Risk Behaviour in Prisons: The Inmates' Perspective. Toronto, ON: University of Toronto HIV, Social, Behavioural and Epidemiological Studies Unit.
     
     
124. Calzavara, L., Myers, T., Millson, M. Schlossberg, J., Burchell, A. (1997). Understand HIV-related Risk Behaviour in Prisons: The Inmates' Perspective. Toronto, ON: University of Toronto HIV, Social, Behavioural and Epidemiological Studies Unit.
     
     
125. Calzavara, L., Myers, T., Millson, M. Schlossberg, J., Burchell, A. (1997). Understand HIV-related Risk Behaviour in Prisons: The Inmates' Perspective. Toronto, ON: University of Toronto HIV, Social, Behavioural and Epidemiological Studies Unit.
     
     
126. Hankins, C., Gendron, S., Tran, T., Lai-tung, M., Paquette, N., Jalbert, M., et al. (1995). Prior risk factors for HIV infection and current risk behaviours among incarcerated men and women in a medium security correctional institution-Montreal. Canadian Journal of Infectious Disease, 6, 31B.
     
     
127. Hankins, C., Gendron, S., Handley, M., Richard, C., Lan Tung, M., O'Shaughnessy, M.(1994). HIV infection among women in prison: an assessment of risk factors using a nonnominal methodology. American Journal of Public Health, 84, 1637-1640.
     
     
128. Jurgens, R. (1996). HIV/AIDS in Prisons: Final Report. Ottawa, ON: Canadian AIDS Society.
     
     
129. Correctional Services of Canada. (1999). Infectious Disease Surveillance Report, 1999.
     
     
130. Calzavara, L., Myers, T., Millson, M. Schlossberg, J., Burchell, A. (1997). Understand HIV-related Risk Behaviour in Prisons: The Inmates' Perspective. Toronto, ON: University of Toronto HIV, Social, Behavioural and Epidemiological Studies Unit.
     
     
131. Ford, P.M., Pearson, M., Sankar-Mistry, P., Stevenson, T., Bell, D., Austin, J. HIV, Hepatitis C and risk Behaviour in a Canadian Medium-Security Federal Penitentiary. QJM, 93(2),113-9.
     
     
132. Statistics Canada (1998). Adult Correctional Services in Canada, 1996-97. Ottawa, ON: Minister of Industry, Catalogue no. 85-211-XIE, ISSN 1480-8501.
     
     
133. Correctional Service Canada (1996). 1995 National Inmate Survey: Final Report.
     
     
134. Rothon, D., Strathdee, A., Cook, D., & Cornelisse, G.A. (1997). Determinants of HIV-Related High Risk Behaviours Among Young Offenders: A Window of Opportunity. Canadian Journal of Public Health.
     
     
135. Hagan, J., McCarthy, B. (1997). Mean Streets: Youth Crime and Homelessness. Cambridge: Cambridge University Press, 1997.
     
     
136. Radford, J. L., King, A. J. C., Warren, W. K. (1989). Street Youth and AIDS. Kingston, ON: Health and Welfare Canada.
     
     
137. Covenant House (1998). Information Brochure. Toronto, ON: Covenant House.
     
     
138. Radford, J. L., King, A. J. C., Warren, W. K. (1989). Street Youth and AIDS. Kingston, ON: Health and Welfare Canada.
     
     
139. Smart, R. G., Adlaf, E. M. (1991). Substance use and problems among Toronto street youth. British Journal of Addiction, 86, 999-1010.
     
     
140. Smart, R. G., Adlaf, E. M., Walsh, G. W., Zdanowicz, Y. (1992). Drifting & Doing: Changes in Drug Use Among Toronto Street Youth, 1990-1992. Toronto, ON: Addiction Research Foundation.
     
     
141. Anderson, J. (1993). A Study of Out-of-the-Mainstream Youth in Halifax, Nova Scotia. Ottawa, ON: Health Canada.
     
     
142. Adlaf, E., Zdanowicz, Y., Smart, R. (1996). Alcohol and other drug use among street-involved youth in Toronto. Addiction Research, 4, 11-24.
     
     
143. Adlaf, E., Zdanowicz, Y., Smart, R. (1996). Alcohol and other drug use among street-involved youth in Toronto. Addiction Research, 4, 11-24.
     
     
144. Roy, E., Haley, N., Boivin, J-F., Frappier, J-Y., Claessens, C. HIV (1996). Infection Among Montreal Street Youth. Montreal, QC: Groupe de recherche sur les jeunes de la rue et l'infection au VIH.
     
     
145. Roy, E., Lemire, N., Haley, N., Boivin, J-F., Frappier, J-Y., Claessens, C. (1998). Injection drug use among street youth: a dynamic process. Canadian Journal of Public Health, 89, 23-25.
     
     
146. Gillis, L. (1999). Women and HIV Prevention: Review of the Research and Literature. Toronto: Community Research Initiative.
     
     
147. Gillis, L. (1999). Women and HIV Prevention: Review of the Research and Literature. Toronto: Community Research Initiative.
     
     
148. Nadeau, L. (1994). Withdrawal, despair, myth and love: a typology of risk taking contexts for drug dependent women. Paper presented at the Fifth International Conference on the Reduction of Drug Related Harm, Toronto.
     
     
149. Amaro, H. Love, sex and power: considering women's realities in HIV prevention. American Psychologist, 50, 437-447.
     
     
150. Maxwell, J. (1999). HIV prevention research with men who have sex with men: present knowledge; future directions. Toronto, ON: Community Research Initiative of Toronto.
     
     
151. Rhodes, F., Deren, S., Wood, M., Shedlin, M., Carlson, R., Lambert, E., Kochems, L, Stark, M., Falck, R., Wright-DeAguero, L., Weir, B., Cottler, L., Rourke, K., Trotter, R. (in press). Understanding HIV risks of chronic drug-using men who have sex with men. AIDS Care.
     
     
152. Seage, G., Mayer, K., Wold, C., Lenderking, W, Goldstein, R., Cai, B., Gross, M, Heeren, T., Hingson, R. (1998). The social context of drinking, drug use and unsafe sex in the Boston Young Men Study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 17, 368-375.
     
     
153. Allman, D. (1999). M is for Mutual A is for AIDS. Ottawa, ON: Canadian HIV/AIDS Clearinghouse and Health Canada, 1999.
     
     
154. Allman, D., Myers, T. (1999). Male sex work and HIV/AIDS in Canada. In Aggleton, P. (Ed.) Men Who Sell Sex-International Perspectives on Male Prostitution and AIDS. London, ON: UCL Press.
     
     
155. Allman, D. (1999). M is for Mutual A is for AIDS. Ottawa, ON: Canadian HIV/AIDS Clearinghouse and Health Canada, 1999.
     
     
156. Myers, T., Godin, G., Calzavara, L., Lambert, J., Locker, D. (1993). The Canadian Survey of Gay and Bisexual Men and HIV Infection: Men's Survey. Ottawa, ON: Canadian AIDS Society.
     
     
157. Shaver, F., Newmeyer, T. (1996). Men who have sex with men: a comparison of the sexual practices and risk-taking behaviour of gay and bisexual men and male prostitutes. Paper presented at the 64th Conference of ACFAS. Montreal.
     
     
158. DeMatteo, D., Read, S., Bock, B., Coates, R., Goldberg, E., King, S., Millson, P., McLaughlin, P., Major, C., O'Shaughnesssy, M. (1992). HIV seroprevalence in Toronto street youth. Paper presented at the Seventh International Conference on AIDS, Rotterdam.
     
     
159. Read, S., DeMatteo, D., Bock, B., Coates, R., Goldberg, E., King, S., Major, C., McLaughlin, B., Millson, M., O'Shaughnessy, M. (1993). HIV Prevalence in Toronto Street Youth. Toronto, ON: The Hospital for Sick Children.
     
     
160. Miller, M., Strathdee, S., Martindale, S., Cornelisse, P., Hogg, R., Cook, D., Montaner, J., O'Shaughnessy, M., Schechter, M. (1997). Characteristics of male sex trade workers enrolled in a prospective study of HIV incidence. Paper presented to the Sixth Annual Canadian Conference on HIV/AIDS Research, Ottawa.
     
     
161. Rush, B.R., Ogborne, A.C. (1992). Alcoholism Treatment in Canada. History, Current Status and Emerging Issues. In H. Klingemann, J.P. Jakala, G. Hunt (eds), Cure, Care in Control: Alcoholism Treatment in Sixteen Countries. New York: State University Press.
     
     
162. Boyd, N., Millard, C.J., and Webster, C.D. (1985). Heroin "Treatment" in British Columbia, 1976 - 1984: Thesis, Antithesis and Synthesis? Canadian Journal of Criminology, 27(2), 195-208.
     
     
163. Merrill, J. (1998). Evaluating treatment effectiveness: Changing our expectations. Journal of Substance Abuse Treatment, 15, 175-176.
     
     
164. Stoller, K. B. & Biglow, G. E. (1999). Regulator, cost, and policy issues. In E. C. Strain & M. L. Stitzer (Eds.), Methadone Treatment for Opiod Dependence. Baltimore, MY: Johns Hopkins University Press.
     
     
165. Wall, R., et al. (manuscript under review). Social costs of untreated opioid dependence.
     
     
166. United Nations Commission on Narcotic Drugs (1997). Effects on individuals, society and international drug control of the prescription of narcotic drugs to drug addicts (report of the secretariat for the 40th session, Economic and Social Council). Geneva, Switzerland: United Nations Commission on Narcotic Drugs.
     
     
167. Ling, W. & Rawson, R. (1997). American opiate substitution treatment programs: From methadone to LAAM and buprenorphine. In M. Rihs-Middel (Ed.) The Medical Prescription of Narcotics: Scientific Foundations and Practical Experiences (pp. 250-251), Bern, Switzerland: Swiss Federal Office of Public Health.
     
     
168. Litten, R.Z. & Allen, J.P. (1999). Medications for alcohol, illicit drug, and tobacco dependence: An update of research findings. Journal of Substance Abuse Treatment, 16 (2), 105-112.
     
     
169. Stimson, G. V. (1995). AIDS and injecting drug use in the United Kingdom, 1987-1993: The policy response and the prevention of the epidemic. Social Science Medicine, 41 (5), 699-716.
     
     
170. Rihs-Middell, M. (Ed.) (1997). The medical prescription of narcotics: Scientific foundations and practical experiences. Bern, Switzerland: Swiss Federal Office of Public Health.
     
     
171. Riley, D., Teixeira, P. & Hausser, D. (1999). Paper 3: HIV/AIDS policy issues related to large-scale targeted interventions for injection drug users. Paper presented at Dialogue on HIV/AIDS: Policy Dilemmas Facing Governments, Montebello, QC (November 8-10, 1999).
     
     
172. Stimson, G. V. (1995). AIDS and injecting drug use in the United Kingdom, 1987-1993: The policy response and the prevention of the epidemic. Social Science Medicine, 41 (5), 699-716.
     
     
173. Canadian HIV/AIDS Legal Network (1996). HIV/AIDS in prisons: Final report. Ottawa, ON: Canadian HIV/AIDS Legal Network.
     
     
174. Federal Office of Public Health (1995). HIV Prevention Pilot Project Institutions in Hindelbank, Bern, Switzerland: Author.
     
     
175. Kemmesies, U.E. (1999). The open drug scene and the safe injection room offers in Frankfurt and Main 1995. Final report. Hamburg, Germany: European Cities on Drug Policy.
     
     
176. EMCDDA (1999). 1999 Extended Annual Report on the state of the drugs problem in the European Union. Luxembourg: Office for official publications of the European Communities.
     
     
177. Commission on Narcotic Drugs (2000). Report on the Third Session (6 - 15 March 2000), Economic and Social Council, Official Records 2000, Supplement No. 8.
     
     
178. Riley, D., Teixeira, P. & Hausser, D. (1999). Paper 3: HIV/AIDS policy issues related to large-scale targeted interventions for injection drug users. Paper presented at Dialogue on HIV/AIDS: Policy Dilemmas Facing Governments, Montebello, QC (November 8-10, 1999).
     
     
179. Memphis Shelby Crime Commission (no date). Best Practice Number Nine: Processing non-violent drug offenders through treatment-oriented drug courts (online: www.memphiscrime.org).
     
     
180. National Association of Drug Court Professionals (1999). Facts on drug courts (online: www.nadcp.org).
     
     
181. Alberta Alcohol and Drug Abuse Commission (July 2000). Drug courts: Substance abuse intervention within the justice system (draft discussion paper). Edmonton, AB: Author.
     
     
182. Australian National Council on Drugs (not dated). Tough on Drugs Diversion Initiative (online: www.ancd.org.au).
     
     
183. Drug Court of New South Wales (1999). Media Release: Drug Court Background Information (online: www.agd.nsw.gov.au).
     
     
184. Australian National Council on Drugs (1998). Diversion Practices as an Alternative Means of Dealing with Drug Offenders. Communique (online: www.ancd.org.au).
     
     
185. Australian National Council on Drugs (1998). Diversion Practices as an Alternative Means of Dealing with Drug Offenders. Communique (online: www.ancd.org.au).
     
     
186. Solicitor General of Canada (1998, December 9). Government of Canada to award more than $1.5 million under the national strategy on community safety and crime prevention to combat drug-related crimes (press release) (online: www.sgc.gc.ca).
     
     
187. Centre for Addiction and Mental Health (1999, November 11). Canada's only drug treatment court celebrates successful first year (press release) (online: www.camh.net).